Creso Pharma (ASX:CPH) primed to profit from potential changes to U.S. psychedelics laws, page-64

Drawing some random lines doesn't make you a chartist.

There's perhaps some validity to the pennant you suggest in your first chart, but if so, it has broken out to the downside so your chart suggests lower prices in the short term, with quite a sharp drop to come.

The second chart doesn't even come close to resembling anything in the realm of charting patterns.